Skip to main content
Premium Trial:

Request an Annual Quote

Orochem Snaps up Oligonet

NEW YORK (GenomeWeb News) – Reagents and sample prep products firm Orochem Technologies said today that it has acquired Oligonet, a maker of custom synthetic oligonucleotides.

Lombard, Ill.-based Orochem said it purchased Oligonet to advance its goals in the synthetic oligos market.

Orochem already offers DNA and RNA kits, as well as protein purification kits and plates to the academic, government, and industrial research markets. Oligonet, which is located in Gaithersburg, Md., provides synthetic oligodeoxynucleotides and oligonucleotides labeled with multiple modifications and dyes, Orochem said.

Financial terms of the agreement were not released.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.